F. H. Schröder, J. Hugosson, and M. J. Roobol, Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up, The Lancet, vol.384, pp.2027-2035, 2014.

,

A. Bill-axelson, L. Holmberg, and H. Garmo, Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer, N Engl J Med, vol.370, pp.932-942, 2014.

C. U. Jones, M. P. Chetner, and M. Rotman, Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer, N Engl J Med, vol.365, issue.2, pp.107-125, 2011.

F. Rozet, C. Hennequin, and J. Beauval, Recommandations en onco-urologie 2016-2018 du CCAFU : Cancer de la prostate, Prog En Urol, vol.27, issue.16, pp.30705-30714, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02297771

N. Mottet, J. Bellmunt, and M. Bolla, EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent, Eur Urol, vol.71, pp.618-629, 2017.

A. Briganti, F. Chun, and A. Salonia, Validation of a Nomogram Predicting the Probability of Lymph Node Invasion among Patients Undergoing Radical Prostatectomy and an Extended Pelvic Lymphadenectomy, Eur Urol, vol.49, pp.1019-1027, 2006.

A. Briganti, A. Larcher, and F. Abdollah, Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores, Eur Urol, vol.61, pp.480-487, 2012.

M. Roumiguié, J. Beauval, and T. Filleron, External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer, BJU Int, vol.114, pp.113-119, 2014.

A. Briganti, S. Joniau, and P. Gontero, Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer, Eur Urol, vol.61, pp.584-592, 2012.

A. Heidenreich, C. H. Ohlmann, and S. Polyakov, Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy, Eur Urol, vol.52, pp.29-37, 2007.

L. Mearini, M. Gacci, and O. Saleh, External validation of nomogram predicting the probability of specimen-confined disease (pT2-3a, R0N0) in patients undergoing radical prostatectomy and pelvic lymph node dissection, Urol Int, vol.93, pp.262-268, 2014.

J. Hansen, A. Becker, and L. A. Kluth, Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation, Urol Oncol, vol.33, issue.9, pp.384-385, 2015.

P. Dell'oglio, F. Abdollah, and N. Suardi, External validation of the European association of urology recommendations for pelvic lymph node dissection in patients treated with robot-assisted radical prostatectomy, J Endourol, vol.28, pp.416-423, 2014.

M. Gacci, R. Schiavina, and M. Lanciotti, External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection, Urol Int, vol.90, pp.277-282, 2013.

,

J. Hansen, M. Rink, and M. Bianchi, External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection, The Prostate, vol.73, pp.211-218, 2013.

,

G. Gandaglia, J. D. Sammon, and S. L. Chang, Comparative Effectiveness of Robot-Assisted and Open Radical Prostatectomy in the Postdissemination Era, J Clin Oncol, vol.32, pp.1419-1426, 2014.

J. P. Sherbeck, L. Zhao, and R. W. Lieberman, High Variability in Lymph Node Counts Among an International Cohort of Pathologists: Questioning the Scientific Validity of Node Counts, J Natl Compr Canc Netw, vol.16, pp.395-401, 2018.

A. Heidenreich, D. Pfister, D. Thüer, and B. Brehmer, Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy, BJU Int, vol.107, pp.220-225, 2011.

J. Beauval, B. Cabarrou, and G. Gandaglia, External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients, The Prostate, vol.77, pp.928-933, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01906190

A. V. D'amico, R. Whittington, and S. B. Malkowicz, Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era, Cancer, vol.95, pp.281-286, 2002.